New Israeli drug cured 29 of 30 moderate/serious COVID cases in days — hospital

Medicine developed at Ichilov moderates immune response, helps prevent deadly cytokine storm, researchers say; 29 of 30 phase 1 trial patients left hospital within 3-5 days.
Read more: https://www.timesofisrael.com/new-israeli-drug-cured-moderate-to-serious-covid-cases-within-days-hospital/?source=Snapzu